MedTrace Logo

The Effectiveness of Sertraline in Patients Who Have Had Inadequate Response to Escitalopram

NCT00179257 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-06-02

No results posted yet for this study

Summary

The purpose of this is to determine the efficacy, safety, and tolerability of sertraline in patients with major depressive disorder (MDD) who have shown inadequate response ot escitalopram.

Conditions

Interventions

DRUG

sertraline (Zoloft)

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Richard C Shelton, MD · Vanderbilt University Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Completion
2005-03-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00179257 on ClinicalTrials.gov